Ameriprise Financial Inc Veru Inc. Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.22 - $23.7 $53,757 - $124,662	-5,260 Reduced 24.06%	16,599 $191,000
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $95,086 - $346,465	21,859 New	21,859 $247,000
Q4 2017 Feb 12, 2018	SELL	$0.98 - $2.27 $12,046 - $27,902	-12,292 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$1.2 - $2.84 $14,750 - $34,909	12,292	12,292 $33,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.